CCL
71
4
CME
56
-3
FTI
69
-7
ED
53
-5
ICE
64
-5
CHRW
48
8
NRG
57
2
MCD
63
-4
AN
49
2
AKAM
56
-2
KMI
59
2
AVY
54
-14
MPC
44
3
GOOGL
53
2
ADSK
65
-2
CRM
50
-5
SWK
80
2
NFLX
55
-3
GE
85
3
TGNA
51
3
CCL
71
4
CME
56
-3
FTI
69
-7
ED
53
-5
ICE
64
-5
CHRW
48
8
NRG
57
2
MCD
63
-4
AN
49
2
AKAM
56
-2
KMI
59
2
AVY
54
-14
MPC
44
3
GOOGL
53
2
ADSK
65
-2
CRM
50
-5
SWK
80
2
NFLX
55
-3
GE
85
3
TGNA
51
3
Financhill
Back

Biomarin Pharmaceutical Quote, Financials, Valuation and Earnings

32,481% Growth? Meet Mode Mobile's "EarnPhone"

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
33

BMRN
Biomarin Pharmaceutical

Last Price:
71.13
Seasonality Move:
5.7%

7 Day Trial

ALL ACCESS PASS

$ 7

Former Chicago Pit Trader Exposes Shocking Trading Advantage:

See How to Target Up to 383% OVERNIGHT

Biomarin Pharmaceutical Price Quote

$71.13
-0.01 (0.82%)
(Updated: September 19, 2024 at 4:58 AM ET)

Biomarin Pharmaceutical Key Stats

Sell
33
Biomarin Pharmaceutical (BMRN) is a Sell
Day range:
$70.11 - $71.58
52-week range:
$68.83 - $99.56
Dividend yield:
0%
P/E ratio:
81.77
P/S ratio:
5.36
P/B ratio:
2.56%
Volume:
2.2M
Avg. volume:
2M
1-year change:
-19.71%
Market cap:
$13.5B
Revenue:
$2.4B
EPS:
$1.33

How Much Does Biomarin Pharmaceutical Make?

Is Biomarin Pharmaceutical Growing As A Company?

Biomarin Pharmaceutical Stock Price Performance

What Is Biomarin Pharmaceutical 52-Week High & Low?

Biomarin Pharmaceutical Price To Free Cash Flow

Is It Risky To Buy Biomarin Pharmaceutical?

Is Biomarin Pharmaceutical Cash Flow Positive?

  • What Is BMRN Cash Flow From Operations?
    Cash flow from operations (TTM) is $328.9M
  • What Is Biomarin Pharmaceutical’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$20.1M
  • What Is Biomarin Pharmaceutical’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$34.5M

Biomarin Pharmaceutical Return On Invested Capital

  • Is Management Doing A Good Job?
    BMRN return on invested capital is 4.22%
  • What Is Biomarin Pharmaceutical Return On Assets?
    ROA measures how assets are converting to revenues and is 3.76%
  • What Is BMRN Return On Equity?
    ROE is a measure of profitability and is 5.13%

Biomarin Pharmaceutical Earnings Date & Stock Price

Biomarin Pharmaceutical Competitors

Biomarin Pharmaceutical Dividend Yield

Biomarin Pharmaceutical Analyst Estimates

YoY Growth Past Surprise
EPS: 89.66% 60.99%
Revenue: 19.61% 7.23%

Analyst Recommendations

Buy Recommendations: 14
Hold Recommendations: 6
Sell Recommendations: 0
Price Target: 104.74
Upside from Last Price: 47.23%

Major Shareholders

  • How many BMRN shares are owned by institutional investors?
    315.6M BMRN shares are owned by institutional investors
  • How many BMRN shares are owned by insiders?
    2.5M BMRN shares are owned by insiders